TGFB1 and COVID-19: In contrast, intracellular TGF-β expression in non-M-MDSCs (HLA-DR-/low CD11b+CD14-TGF-β+ cells) significantly higher in severe COVID-19 patients compared with both moderate COVID-19 and HC groups (Fig. 2B, all P < 0.0001).